Principal Component Analysis of Alternative Splicing Profiles Revealed by Long-Read ONT Sequencing in Human Liver Tissue and Hepatocyte-Derived HepG2 and Huh7 Cell Lines
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115502 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elizaveta Sarygina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Chemistry, Pogodinskaya Street 10, 119121 Moscow, Russia. Hauptthemen laut MEDLINE: Alternative Splicing, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Russian Federation.
Abstract (Originalsprache)
The long-read RNA sequencing developed by Oxford Nanopore Technology provides a direct quantification of transcript isoforms. That makes the number of transcript isoforms per gene an intrinsically suitable metric for alternative splicing (AS) profiling in the application to this particular type of RNA sequencing. By using this simple metric and recruiting principal component analysis (PCA) as a tool to visualize the high-dimensional transcriptomic data, we were able to group biospecimens of normal human liver tissue and hepatocyte-derived malignant HepG2 and Huh7 cells into clear clusters in a 2D space. For the transcriptome-wide analysis, the clustering was observed regardless whether all genes were included in analysis or only those expressed in all biospecimens tested. However, in the application to a particular set of genes known as pharmacogenes, which are involved in drug metabolism, the clustering worsened dramatically in the latter case. Based on PCA data, the subsets of genes most contributing to biospecimens’ grouping into clusters were selected and subjected to gene ontology analysis that allowed us to determine the top 20 biological processes among which translation and processes related to its regulation dominate. The suggested metrics can be a useful addition to the existing metrics for describing AS profiles, especially in application to transcriptome studies with long-read sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Chemistry, Pogodinskaya Street 10, 119121 Moscow, Russia.
- Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilova 32, 119991 Moscow, Russia.
ORCID-Profile: Anna Kozlova, Pavel Spirin, Vladimir S Prassolov
Förderung
- Ministry of Education and Science of the Russian Federation
Zitieren
APA
Sarygina, E., Kozlova, A., Deinichenko, K., Radko, S., Ptitsyn, K., Khmeleva, S., Kurbatov, L. K., Spirin, P., Prassolov, V. S., Ilgisonis, E., Lisitsa, A., & Ponomarenko, E. (2023). Principal Component Analysis of Alternative Splicing Profiles Revealed by Long-Read ONT Sequencing in Human Liver Tissue and Hepatocyte-Derived HepG2 and Huh7 Cell Lines. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115502
Vancouver
Sarygina E, Kozlova A, Deinichenko K, Radko S, Ptitsyn K, Khmeleva S, et al. Principal Component Analysis of Alternative Splicing Profiles Revealed by Long-Read ONT Sequencing in Human Liver Tissue and Hepatocyte-Derived HepG2 and Huh7 Cell Lines. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115502
BibTeX
@article{Sarygina2023,
author = {Sarygina, Elizaveta and Kozlova, Anna and Deinichenko, Kseniia and Radko, Sergey and Ptitsyn, Konstantin and Khmeleva, Svetlana and Kurbatov, Leonid K and Spirin, Pavel and Prassolov, Vladimir S and Ilgisonis, Ekaterina and Lisitsa, Andrey and Ponomarenko, Elena},
title = {Principal Component Analysis of Alternative Splicing Profiles Revealed by Long-Read ONT Sequencing in Human Liver Tissue and Hepatocyte-Derived HepG2 and Huh7 Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115502}
}
EUVIMED